Malta for Biotech / Life Sciences

Why Malta Works for Biotech / Life Sciences

Family viability (100/100) is a genuine strength for Malta - important for Biotech / Life Sciences founders relocating with a partner or children. The cost of living index is 72 (NYC = 100), with a comfortable family monthly budget of $6K. Safety scores 72/100. International schools are available, and healthcare quality scores 74/100 with private insurance running approximately $250/month.

Operational ease (86/100) makes Malta practical for Biotech / Life Sciences founders setting up from scratch. Banking difficulty for foreigners is rated moderate. Company formation takes approximately 7 days at a cost of around $2K, with annual compliance costs around $3K. Full foreign ownership is permitted - no local partner required. IP protection quality is rated moderate, which matters for Biotech / Life Sciences businesses with proprietary technology or brand assets.

Funding access (85/100) is a standout for Malta Biotech / Life Sciences companies. The local market has 18 active VC funds, with average seed checks of $400K. Government grant programs include Malta Enterprise R&D Grant ($200K) and ERDF/ESF EU Funds ($500K). Non-dilutive capital availability reduces the pressure to give up equity at early stage, which is particularly valuable for capital-efficient Biotech / Life Sciences businesses.

Watch Outs for Biotech / Life Sciences Founders in Malta

Corporate tax (25/100): Tax efficiency is not the primary reason to choose Malta for Biotech / Life Sciences operations. Founders whose primary goal is minimising the corporate tax line should model effective rates carefully and compare against jurisdictions with zero or near-zero corporate tax.

Ecosystem depth (50/100): The local startup ecosystem is less developed than leading hubs. Biotech / Life Sciences founders who depend on domain-specific mentors, accelerators, or local angel networks may find the community thinner than in Europe or Singapore. Remote-first operations and access to global networks can compensate, but this is a real consideration for companies that benefit from in-person founder density.